Correlation Between Navidea Biopharmaceutica and NextCure
Can any of the company-specific risk be diversified away by investing in both Navidea Biopharmaceutica and NextCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Navidea Biopharmaceutica and NextCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Navidea Biopharmaceuticals and NextCure, you can compare the effects of market volatilities on Navidea Biopharmaceutica and NextCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Navidea Biopharmaceutica with a short position of NextCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Navidea Biopharmaceutica and NextCure.
Diversification Opportunities for Navidea Biopharmaceutica and NextCure
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Navidea and NextCure is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Navidea Biopharmaceuticals and NextCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCure and Navidea Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Navidea Biopharmaceuticals are associated (or correlated) with NextCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCure has no effect on the direction of Navidea Biopharmaceutica i.e., Navidea Biopharmaceutica and NextCure go up and down completely randomly.
Pair Corralation between Navidea Biopharmaceutica and NextCure
If you would invest 9.96 in Navidea Biopharmaceuticals on September 3, 2024 and sell it today you would earn a total of 0.00 from holding Navidea Biopharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 1.56% |
Values | Daily Returns |
Navidea Biopharmaceuticals vs. NextCure
Performance |
Timeline |
Navidea Biopharmaceutica |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
NextCure |
Navidea Biopharmaceutica and NextCure Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Navidea Biopharmaceutica and NextCure
The main advantage of trading using opposite Navidea Biopharmaceutica and NextCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Navidea Biopharmaceutica position performs unexpectedly, NextCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCure will offset losses from the drop in NextCure's long position.Navidea Biopharmaceutica vs. NovaBay Pharmaceuticals | Navidea Biopharmaceutica vs. Cyclacel Pharmaceuticals | Navidea Biopharmaceutica vs. Tenax Therapeutics |
NextCure vs. Milestone Pharmaceuticals | NextCure vs. Seres Therapeutics | NextCure vs. DiaMedica Therapeutics | NextCure vs. Lyra Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |